Out-licensing

Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More

An Endothelial lined Stent for Rapid Endothelialization and Preventing Restenosis More

The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More

A strategy for artificially inducing the internalization of surface receptors, thereby blocking the effects of the ligands associated with that receptor More

Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More

Compositions and methods which employ a combination of monoclonal antibodies which bind to HGF and prevent it from binding to its receptor met in a manner that HGF/met signaling is neutralized More